Markets › India › NSE › SYMBIOTEC

Symbiotec Pharmalab Limited

NSE:SYMBIOTECHealth TechnologyNSE:NIFTY_IPO

₹1,238.60−3.20%At closeAt close · Mon 19 Oct · ≈ AED 47.86 · Market cap $864.27M

Ratio	FY2022	FY2023	FY2024	YoY
Gross margin	14.3%	24.7%	27.8%	+3.1 pts
Operating margin	5.6%	17.3%	20.2%	+2.9 pts
Net margin	4.3%	14.3%	13.1%	−1.2 pts
EBITDA margin	10.7%	22.8%	26.0%	+3.2 pts
Return on equity	3.8%	14.0%	11.9%	−2.1 pts
Return on assets	2.4%	7.7%	6.1%	−1.6 pts
Return on capital employed	4.0%	12.9%	13.4%	+0.6 pts
Debt / equity	0.4×	0.4×	0.7×	+90.6%
Debt / assets	22.2%	19.4%	34.5%	+15.1 pts
Interest coverage	3.8×	15.2×	8.8×	−42.3%
Current ratio	1.8×	1.4×	1.0×	−27.9%
Quick ratio	0.7×	0.5×	0.5×	+1.7%
Cash ratio	0.0×	0.0×	0.1×	+161.7%
Asset turnover	0.6×	0.5×	0.5×	−13.8%
Inventory turnover	1.9×	1.5×	2.0×	+29.5%
Receivables turnover	3.9×	5.0×	3.8×	−23.3%
Dividend payout	0.0%	0.0%	0.0%	—

Margins, returns, leverage and liquidityUpdated 31 Mar 2025 ·

ⓘ